Navigation Links
Imprimis Announces Key Leadership Appointments
Date:2/21/2013

NEW DELHI, February 21, 2013 /PRNewswire/ --

Focuses on Growth, Expansion in Sectors Like Biotechnology, Education, Retail, Corporate

Imprimis PR, one of the leading communications consultancies in India with focus on the healthcare and pharma sectors, announced key leadership appointments in New Delhi today. The firm will be undertaking a thorough forensic audit with Ernst & Young after the immediate release of the former CEO Mr. Aman Gupta and set the stage for implementing its future expansion plans.

Strengthening its leadership team, Imprimis has appointed Ms. Gracelle Gerber , a seasoned communication professional with expertise in reputation management and strategic advocacy and former SVP International at Baird's, as the CEO of Imprimis. Gerber joins Imprimis with international expertise and experience in the healthcare and pharma sector as well as industries like ICT, manufacturing, consumer, agriculture and tourism. She has worked extensively across India, Africa and Brazil. Included amongst a wide range of global FDI clients, she was the lead strategic business director for the Tata Group in Africa over the past decade, before moving to India on a full-time basis.

Ms. Nymphia Vishin, formerly the Chief Strategy Analyst at Imprimis, has been appointed the Deputy CEO of the firm. Vishin has been associated with Imprimis for over seven years, working in various leadership positions assisting key clients for their communication mandates. Her experience of working with clients, cutting across a diverse set of industries, gives her the ability to understand business complexities and successfully design communication programs that are suited to specific local needs.

Ms. Tanya Kewalramani has also been inducted as the Chief Science Communications Officer at Imprimis. Kewalramani, a Science Communications professional, holding a Masters degree from the prestigious Australian National University, will be responsible for building the biotechnology division for Imprimis in the coming years.

Dilip Cherian , Consulting Partner, Perfect Relations Group said, "As a team we are getting aggressive and looking at opportunities to scale new heights. We will be looking at new sectors and vectors of growth. Our aim is to conquer new skills of having people who have the confidence of the skills they possess so that we can look at providing services that were never before possible. Today, client needs are based on the fact that the markets are extremely competitive. Knowledge and constant practice with the much needed quality will aid in achieving far more growth and help sustaining it in the long run." 

The appointments are in line with the company's overall plans to expand presence in the Indian markets and strengthen its position across key sectors including biotechnology, education, retail and corporate other than the healthcare and pharma domain in which it's already a leader.

About Imprimis PR

Imprimis, part of the Perfect Relations Group, India's foremost independent communications firm, gained stronghold in the healthcare and pharma space over the last decade working with a slew of domestic and international pharma majors. The firm has been associated with organisations like Novartis, Lilly, Gilead, GSK, Sanofi, Apollo Hospitals, Fortis Healthcare, Jubilant Life Sciences, etc. and in recent years expanded its portfolio to include clients from education, IT/Telecom and retail sectors. Similarly, Imprimis has also been active in the CSR space working with large social institutes like the Bill & Melinda Gates Foundation, WHO, and International Aids Vaccine Initiative to name a few. For more information, visit www.imprimispr.com

Primary Media Contact: Nymphia Vishin, nvishin@imprimispr.com, 91-11-46668666


'/>"/>
SOURCE Imprimis PR
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
9. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
10. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
11. Misonix Announces New Distribution Agreement For Panama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):